Czechia: Preventive Healthcare

Life expectancy at birth (in years), 2023: 79.9 years
Main causes of mortality (age-standardized rate per 100,000 population), 2023
– Circulatory system: 372
– Neoplasms: 219
– Respiratory system: 71
– External causes: 46
– Other: 228
Mortality from preventable causes (age-standardized rate per 100,000 population)
– 2023: 142
– 2013: 181
Mortality from treatable causes (age-standardized rate per 100,000 population)
– 2023: 87
– 2013: 116
Maternal mortality (deaths per 100,000 live births)
– 2021-2023: 6.0
– 2011-2013: 5.8
Infant mortality (deaths per 1 000 live births)
– 2021-2023: 2.2
– 2011-2013: 2.6
Percentage of eligible children who have received two doses of a measles-containing vaccine, 2024: 89%
Percentage of eligible children who have received three doses of the diphtheria, tetanus and pertussis vaccine, 2024: 86%
Percentage of population aged 65 and over vaccinated against influenza
– 2023: 25%
– 2019: 23%
Mammography screening within the past two years (% of women aged 50-69 screened)
– 2023: 60%
– 2013: 58%
Cervical cancer screening coverage (% of women screened), 2023: 75%
Colorectal cancer screening coverage (% of target population screened), 2023: 30%
Asthma and chronic obstructive pulmonary disease hospital admissions in adults (age-sex standardized rate per 100,000 population)
– 2023: 140
– 2013: 210
Congestive heart failure hospital admissions in adults (age-sex standardized rate per 100,000 population)
– 2023: 355
– 2013: 445
Diabetes hospital admissions in adults (age-sex standardized rate per 100,000 population)
– 2023: 97
– 2013: 198

Source: OECD (2025), Health at a Glance 2025: OECD Indicators, OECD Publishing, Paris, doi.org/10.1787/8f9e3f98-en.

Life expectancy at birth (years), 2021: 77.1 years
Maternal mortality ratio (per 100,000 live births), 2023: 3
Under-five mortality rate (per 1000 live births), 2023: 2.6
Neonatal mortality rate (per 1000 live births), 2023: 1.3
New HIV infections (per 1000 uninfected population), 2023: <0.1
Tuberculosis incidence (per 100,000 population), 2023: 4.8
Probability of dying from any of cardiovascular disease, cancer, diabetes, chronic respiratory disease between age 30 and exact age 70 (%), 2021: 14.2%
Suicide mortality rate (per 100,000 population), 2021: 13.3
Adolescent birth rate (per 1000 women aged 15-19 years), 2015-2024: 7.2
Adolescent birth rate (per 1000 women aged 10-14 years), 2015-2024: 0.1
Diphtheria-tetanus-pertussis (DTP3) immunization coverage among 1-year-olds (%), 2023: 94%
Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%), 2023: 90%
Human papillomavirus (HPV) immunization coverage estimates among 15 year-old girls (%), 2023: 72%
Prevalence of stunting in children under 5 (%), 2024: 2.4%
Prevalence of overweight in children under 5 (%), 2024: 6.6%
Prevalence of anaemia in women aged 15-49 years (%), 2023: 24.6%

Source: World health statistics 2025: monitoring health for the SDGs, Sustainable Development Goals. Tables of health statistics by country and area, WHO region and globally. Geneva: World Health Organization; 2025. Licence: CC BY-NC-SA 3.0 IGO.

Under-Five Mortality Rate (per 1,000 live births), 2022: 3
Infant Mortality Rate (per 1,000 live births), 2022: 2
Neonatal Mortality Rate (per 1,000 live births), 2022: 1
Mortality Rate Among Children Aged 5-14 Years (per 1,000 children aged 5), 2022: 1
Maternal Mortality Ratio (per 100,000 live births), 2020: 3
Lifetime Risk of Maternal Death (1 in x), 2020: 1 in 17,032
Immunization for Vaccine Preventable Diseases (%), 2023
– Percentage of surviving infants who received the first dose of diphtheria, pertussis and tetanus vaccine: 98%
– Percentage of surviving infants who received three doses of diphtheria, pertussis and tetanus vaccine: 95%
– Percentage of surviving infants who received three doses of the polio vaccine: 95%
– Percentage of surviving infants who received the first dose of the measles-containing vaccine: 82%
– Percentage of children who received the second dose of measles-containing vaccine as per national schedule: 80%
– Percentage of surviving infants who received three doses of hepatitis B vaccine: 95%
– Percentage of surviving infants who received three doses of Haemophilus influenzae type b vaccine: 95%
– Percentage of surviving infants who received three doses of pneumococcal conjugate vaccine: 74%
Adolescent Birth Rate (Births Per 1,000 Adolescent Girls and Young Women), 2017-2023
– Aged 10-14: 0
– Aged 15-19: 7

Notes: Under-five mortality rate – Probability of dying between birth and exactly 5 years of age, expressed per 1,000 live births.
Infant mortality rate – Probability of dying between birth and exactly 1 year of age, expressed per 1,000 live births.
Neonatal mortality rate – Probability of dying during the first 28 days of life, expressed per 1,000 live births.
Mortality rate (children aged 5 to 14 years) – Probability of dying at age 5–14 years expressed per 1,000 children aged 5.
Maternal mortality ratio – Number of deaths of women from pregnancy-related causes per 100,000 live births during the same time period (modelled estimates).
Lifetime risk of maternal death – Lifetime risk of maternal death takes into account both the probability of becoming pregnant and the probability of dying as a result of that pregnancy, accumulated across a woman’s reproductive years (modelled estimates).
BCG – Percentage of live births who received bacilli Calmette-Guérin (vaccine against tuberculosis).
DTP1 – Percentage of surviving infants who received the first dose of diphtheria, pertussis and tetanus vaccine.
DTP3 – Percentage of surviving infants who received three doses of diphtheria, pertussis and tetanus vaccine.
Polio3 – Percentage of surviving infants who received three doses of the polio vaccine.
MCV1 – Percentage of surviving infants who received the first dose of the measles-containing vaccine.
MCV2 – Percentage of children who received the second dose of measles-containing vaccine as per national schedule.
HepB3 – Percentage of surviving infants who received three doses of hepatitis B vaccine.
Hib3 – Percentage of surviving infants who received three doses of Haemophilus influenzae type b vaccine.
Rota – Percentage of surviving infants who received the last dose of rotavirus vaccine as recommended.
PCV3 – Percentage of surviving infants who received three doses of pneumococcal conjugate vaccine.
Protection at birth (PAB) – Percentage of newborns protected at birth against tetanus with tetanus toxoid.
Adolescent birth rate – Number of births per 1,000 adolescent girls and young women aged 10–14 and 15–19.

Source: United Nations Children’s Fund, The State of the World’s Children 2024: The Future of Childhood in a Changing World – Statistical Compendium. UNICEF, Nov. 20, 2024.

“Mortality rates from preventable and treatable causes in Czechia are 25 % higher than the EU averages. Substantial room for improvement remains for public health interventions to reduce premature deaths from preventable causes and to provide more timely and effective healthcare to reduce mortality from treatable causes.”

Source: OECD/European Observatory on Health Systems and Policies (2023), Czechia: Country Health Profile 2023, State of Health in the EU, OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels.

“In 2021, Czechia distributed health expenditure evenly between inpatient and outpatient care, with each accounting for 30 % of the total (Figure 10).Pharmaceutical expenses represented 16 % of health spending2, while long-term care (LTC) accounted for 13 %. Smaller proportions were allocated to prevention (8 %) and administration and other spending (3 %).”

“Czechia’s spending on prevention in absolute per capita terms was only slightly below the EU average in 2021. Between 2020 and 2021, it increased almost 2.5 times, reflecting COVID-19-related spending on preventive measures such as vaccinations and testing.”

Czechia: Preventive Healthcare - National Policies - World Health Systems Facts

World Health Systems Facts is a project of the Real Reporting Foundation. We provide reliable statistics and other data from authoritative sources regarding health systems and policies in the US and sixteen other OECD member nations.

Page last updated May 3, 2026 by Doug McVay, Editor.